Daniel K. Kajdasz

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆

Jon I. Russell, Philip J. Mease, Timothy R. Smith et al. · Pain · 2008 · 369 citations

Medicine, Pharmacology, Pharmacotherapy +17

Estimation of minimum clinically important difference for pain in fibromyalgia

Philip J. Mease, Michael Spaeth, Daniel J. Clauw et al. · Arthritis Care & Research · 2011 · 167 citations · Full text

Nursing, Pharmacotherapy, Pain Management +15

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies

Daniel K. Kajdasz, Smriti Iyengar, D. Desaiah et al. · Clinical Therapeutics · 2007 · 141 citations

Medicine, Pharmacology, Pharmacotherapy +17

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass

Michael S. Avidan, Jerrold H. Levy, Hugo Van Aken et al. · Journal of Thoracic and Cardiovascular Surgery · 2005 · 133 citations · Full text

Medicine, Hematology, Perioperative Medicine +12

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

Arif Khan, Andrew J. Cutler, Daniel K. Kajdasz et al. · The Journal of Clinical Psychiatry · 2011 · 131 citations

Medicine, Pharmacology, Pharmacotherapy +17